Hematology TimesCase suggests GSIs could treat Notch-mutated ALLOctober 8, 2015Leukemia, Myelodysplasia, TransplantationALL
Hematology TimesStudy reveals tumor suppressor in AMLOctober 7, 2015Leukemia, Myelodysplasia, TransplantationAML
Hematology NewsMHM: Novel agents, combos show promise for relapsed/refractory CLLOctober 2, 2015CLLLeukemia, Myelodysplasia, Transplantation
Hematology NewsMHM: Novel agents, combos show promise for relapsed/refractory CLLOctober 2, 2015CLLLeukemia, Myelodysplasia, Transplantation
Hematology NewsChromosome 3 abnormalities linked to poor CML outcomesOctober 2, 2015CMLLeukemia, Myelodysplasia, Transplantation
Hematology NewsChromosome 3 abnormalities linked to poor CML outcomesOctober 2, 2015CMLLeukemia, Myelodysplasia, Transplantation
Hematology TimesNew chimeric CD19 antibody may reduce MRD in ALLOctober 1, 2015Leukemia, Myelodysplasia, TransplantationALL
Hematology TimesGroup calls for more investment in radiotherapyOctober 1, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaRelated Issues
Hematology TimesNonviral gene transfer of CARs tested in humansSeptember 30, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersTransplantationALL
Hematology TimesProblems in pediatric cancer care in EuropeSeptember 30, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPediatrics
Hematology TimesCHMP endorses expanded indication for azacitidineSeptember 30, 2015Leukemia, Myelodysplasia, TransplantationPharmacyAML
Hematology TimesPregnant cancer patients: Start treatment ASAPSeptember 29, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
Hematology TimesCHMP recommends blinatumomab for ALLSeptember 29, 2015Leukemia, Myelodysplasia, TransplantationPharmacyALL
Hematology TimesVariations in blood cancer survival across EuropeSeptember 28, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaAMLHodgkin LymphomaCMLNon-Hodgkin Lymphoma
Hematology TimesNICE backs discounted idelalisib for CLLSeptember 27, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
